SCHEDULE 13G
Statement of Beneficial Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001104659-26-128728
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| ADAR1 Capital Management, LLC | 6,648,027 | 8.7% |
| Daniel Schneeberger | 6,648,027 | 8.7% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Loading xslSCHEDULE_13G_X02/primary_doc.xml…